Status: Not yet recruiting
Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies
The purpose of this prospective, observational study is to evaluate the tolerability and acceptability of Zero minis, a range of protein substitute tablets for use in the dietary management of children with either TYROSINAEMIA Type I, II, III or ALKAPTONURIA, HOMOCYSTINURIA, or MAPLE SYRUP URINE DISEASE (MSUD) over the age of 7 years.
Participants needed: 15
Trial details
Age: 7-18Biological sex: AllType: ObservationalSponsor: metaX Institut fuer Diatetik GmbHUpdated: Mar 7, 2024
Eligibility criteria
Diagnosis of Tyrosinaemia type I, II III or Alkaptonuria requiring a tyrosine- a... [+5]
Presence of serious concurrent illness [+4]